論文

査読有り
2019年4月

The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • Yazu H
  • ,
  • Shimizu E
  • ,
  • Aketa N
  • ,
  • Dogru M
  • ,
  • Okada N
  • ,
  • Fukagawa K
  • ,
  • Fujishima H

122
4
開始ページ
387
終了ページ
392.e1
DOI
10.1016/j.anai.2019.01.004

リンク情報
DOI
https://doi.org/10.1016/j.anai.2019.01.004
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/30639466